Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial
Top Cited Papers
Open Access
- 21 August 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 1 (7), 515-523
- https://doi.org/10.1016/s2213-2600(13)70166-8
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research (PB-PG-1208-18134)
- National Institutes of Health (AG027472, AG035117, HL111111)
This publication has 42 references indexed in Scilit:
- Factors Predisposing to Coma and DeliriumCritical Care Medicine, 2013
- The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studiesCritical Care, 2012
- Delirium as a predictor of long-term cognitive impairment in survivors of critical illnessCritical Care Medicine, 2010
- A national survey of the management of delirium in UK intensive care unitsQJM: An International Journal of Medicine, 2010
- Delirium epidemiology in critical care (DECCA): an international studyCritical Care, 2010
- Days of Delirium Are Associated with 1-Year Mortality in an Older Intensive Care Unit PopulationAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Routine delirium monitoring in a UK critical care unitCritical Care, 2009
- Interventions for preventing delirium in hospitalised patientsPublished by Wiley ,2007
- Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care UnitJAMA, 2004
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1999